ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ONVO Organovo Holdings Inc

1.02
0.01 (0.99%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 43,870
Bid Price 1.01
Ask Price 1.09
News -
Day High 1.05

Low
0.8911

52 Week Range

High
2.33

Day Low 1.01
Share Name Share Symbol Market Stock Type
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.99% 1.02 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.01 1.01 1.05 1.03 1.01
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
342 43,870 US$ 1.04 US$ 45,543 - 0.8911 - 2.33
Last Trade Type Quantity Price Currency
18:56:44 66 US$ 1.0398 USD

Organovo Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
10.34M 10.04M - 370k -17.26M -1.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Organovo News

Date Time Source News Article
2/08/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
2/08/202415:56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202415:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/07/202407:05Edgar (US Regulatory)Form 8-K - Current report
1/26/202416:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
1/25/202407:05GlobeNewswire Inc.Organovo Presents FXR314 3D Human Tissue Model Findings That..
1/09/202407:05GlobeNewswire Inc.Organovo To Present FXR314 IBD 3D Model Findings at Upcoming..
12/28/202315:05Edgar (US Regulatory)Form 8-K - Current report
12/22/202305:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/202307:05GlobeNewswire Inc.Organovo Provides Timing for Release of FXR314 Phase 2 NASH..
12/01/202315:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
11/17/202317:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ONVO Message Board. Create One! See More Posts on ONVO Message Board See More Message Board Posts

Historical ONVO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.041.200.991.03238,756-0.02-1.92%
1 Month1.001.240.9811.05144,9250.022.00%
3 Months1.201.240.89111.06119,327-0.18-15.00%
6 Months1.312.050.89111.24162,174-0.29-22.14%
1 Year2.282.330.89111.3096,112-1.26-55.26%
3 Years9.2811.250.89114.1396,334-8.26-89.01%
5 Years0.981123.920.19331.97417,6000.03893.96%

Organovo Description

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Your Recent History

Delayed Upgrade Clock